Zolmitriptan
Back to searchMolecule Structure
Scientific Name
Zolmitriptan
Description of the Drug
Zolmitriptan is a member of the triptan class of 5-HT(1B/1D/1F) receptor agonist drugs used for the acute treatment of migraine with or without aura in adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00315
http://www.drugbank.ca/drugs/DB00315
Brand Name(s)
Zolmitriptan, Zomig, Zomig-zmt
Company Owner(s)
Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Invagen Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Pld Acquisitions Llc, Zydus Pharmaceuticals Usa Inc, Sun Pharma Global Fze, Ajanta Pharma Ltd, Aurobindo Pharma Ltd, Ani Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin 1b (5-HT1b) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1898 |
| Serotonin 1d (5-HT1d) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1983 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL33336 | |
| Human Metabolome Database | HMDB0014460 | |
| DrugBank | DB00315 | |
| PubChem: Thomson Pharma | 14897880 | 14922369 |
| PubChem | 60857 | |
| LINCS | LSM-3208 | |
| Nikkaji | J694.097H | |
| BindingDB | 50033383 | |
| EPA CompTox Dashboard | DTXSID8045933 | |
| DrugCentral | 2869 | |
| ChemicalBook | CB3313219 | |
| Guide to Pharmacology | 60 | |
| rxnorm | ZOMIG | ZOLMITRIPTAN |
| PubChem: Drugs of the Future | 12014671 | |
| KEGG Ligand | C07218 | |
| ChEBI | 10124 | |
| ZINC | ZINC000000015515 |
